Multiple studies have linked a genetic variant in CHRNA5 exon 5 (rs16969968) with susceptibility to lung cancer, both through indirect effects on nicotine dependence and smoking behaviour, and through direct tumour cell-intrinsic effects [73–76]. This evidence concerns the gene CHRNA5 and lung cancer.